Ensoma Launches, Enters Collaboration with Takeda
- Posted by ISPE Boston
- On March 3, 2021
Boston-based Ensoma, formally launched in early February, has entered into a strategic collaboration with Takeda. The agreement grants Takeda an exclusive worldwide license to Ensoma’s Engenious™ vectors for up to five rare disease indications. Takeda will make an equity investment of $10 million in Ensoma’s Series A Preferred Stock with the potential for $100 million […]
Read More